CAI Caris Life Sciences
Sector: Saúde · 1 fundos · 1 cartas
Convicção fund × trimestre
Teses por gestor
ClearBridge Select Strategy Q2 2025 manter conv. core
Empresa AI-driven em cancer care e genetic profiling. Detida há vários anos na área de private investment do Strategy. Caris went public no fim do trimestre e oferece molecular profiling services diferenciados a empresas biofarmacêuticas usando machine learning algorithms.
The Strategy also saw strong performance from Caris Life Sciences, an AI-driven company in cancer care and genetic profiling. We have owned the company for several years in the private investment area of the strategy. Caris went public late in the quarter and offers a differentiated molecular profiling services to biopharmaceutical companies using machine learning algorithms.
"O Strategy também viu strong desempenho da Caris Life Sciences, empresa AI-driven em cancer care e genetic profiling. Detemos a empresa há vários anos na área de private investment do strategy. A Caris went public no final do trimestre e oferece molecular profiling services diferenciados a empresas biofarmacêuticas usando machine learning algorithms."